CTA Coffee Chat: Northern Edition

​Want to learn more about the Cancer Tech Accelerator Programme 2026?

​​Come get to know the team and ask any questions over a cup of coffee on us!

​​About CTA

​​Backed by Cancer Research UK and Cancer Research Horizons, the Cancer Tech Accelerator (CTA) provides projects with access to funding, mentorship, technical expertise, regulatory guidance, and other resources that can help them validate their technologies and bring their products to market more quickly.

​​Key benefits of the programme include:

• ​​Online and hybrid educational workshops tailored to the cancer tech journey like IP strategy, NHS procurement, market dynamics

• ​​Bespoke mentoring with international experts on themes like oncology, market access, clinical validation, and growth

• ​​Investor introductions and pitching to top UK medtech funds

• ​​Award funding in Phase II to catalyse your idea

• ​​Dynamic cohort of peers across the cancer tech space

​​There is also no equity taken, and it is open to academics, students, researchers, innovators, industry, and entrepreneurs.

​​Learn more about the programme and complete your application here: https://www.cancertechaccelerator.co.uk/. These are questions we ask.